Once Upon A Gene
Download on the App Store

Once Upon A Gene episodes

  • Episode 228 - Strength In Unity - The Power of Consolidated Rare Disease Advocacy, Collaborative Breakthroughs, and the Every Cure Initiative with Dr. David Fajgenbaum

    ONCE UPON A GENE - EPISODE 228

    Strength In Unity - The Power of Consolidated Rare Disease Advocacy, Collaborative Breathroughs, and the Every Cure Initiative with Dr. David Fajgenbaum


    Dr. David Fajgenbaum is is a groundbreaking physician-scientist, disease hunter, speaker, and national bestselling author of Chasing My Cure: A Doctor's Race to Turn Hope Into Action. He joins me to discuss the critical role of unity among our rare disease patient advocacy organizations and why it's important to stick together. We'll also talk about the transformative potential of everycare initiative.


    EPISODE HIGHLIGHTS


    Why is it critical for rare disease advocacy organizations to strive for unity?

    When there's splintering of fracturing among disease groups, there are less resources within each effort and there's a risk of duplicating efforts. There are also only so many experts to participate in a scientific advisory board and there may be competition for those experts among groups.


    What is your best advice for organizations who may be experiencing competition or friction?

    Friction happens because we care so much and we're driven to find treatments and solutions. When you want rapid solutions, it's important to recognize that the objectively best and fastest way to make an impact is working together collaboratively and consolidating resources.


    What advice do you have for ultra-rare disease organizations that are worldwide and have a unique issue of centralizing patients and financial strength?

    In the past I've seen this done well where existing organizations support new organizations starting in new regions of the world by sharing resources and materials and being a supportive partner. It's critical for disease organizations to work together on a global scale.


    Can you tell us about Every Cure and how it aims to revolutionize treatments for rare diseases?

    Every Cure is on a mission to unlock the full potential of every approved drug to treat every disease possible. When a drug is approved for one condition, there's often dozens of other diseases that the drug might be effective in. Every Cure was launched when learning that there was an incredible untapped opportunity to treat more diseases than approved drugs were originally intended for. There are also systemic barriers that prevent the untapped potential from being tapped into. I'm alive, along with thousands of other patients, because of drugs not intended for a disease that we re-purposed.



    LINKS AND RESOURCES MENTIONED

    Chasing My Cure: A Doctor's Race to Turn Hope into Action; A Memoir

    https://chasingmycure.com/books/

    Every Cure

    https://everycure.org/

    ONCE UPON A GENE - EPISODE 043 - David Fajgenbaum - Chasing My Cure - A Doctor's Race to Turn Hope into Action

    https://effieparks.com/podcast/episode-43-david-fajgenbaum

    Share Your Drug Repurposing Insights

    https://everycure.org/insights/



    CONNECT WITH EFFIE PARKS

    Website

    https://effieparks.com/

    Twitter

    https://twitter.com/OnceUponAGene

    Instagram

    https://www.instagram.com/onceuponagene.podcast/?hl=en

    Built Ford Tough Facebook Group

    https://ww

    w.facebook.com/groups/1877643259173346/

    52 min
  • From Classrooms to Communities - Parents Visionary Journey in Education, Living, and Advocacy for Inclusion and Epilepsy Funding with Jillian and Scott Copeland

    ONCE UPON A GENE - EPISODE 226

    From Classrooms to Communities - Parents Visionary Journey in Education, Living, and Advocacy for Inclusion and Epilepsy Funding with Jillian and Scott Copeland


    Jillian and Scott Copeland are husband and wife, advocates and pioneers who have transformed their personal journey of having a child diagnosed with epilepsy. They have taken off on a quest to create supportive and inclusive environments for kids with disabilities and founded a school, an inclusive living community and the Epilepsies Action Network. They're a force also shaping the policy landscape.


    EPISODE HIGHLIGHTS


    Can you first tell us about yourselves and your family?

    Our journey started about 30 years ago and we've had four sons. Our third son, Nicol, is about to turn 25 years old and when he was 8 months old, he had a prolonged seizure for over two hours and it took us on a different parenting journey than we expected. Since then, we've raised our children together and explored opportunities and possibilities for Nicol, which took us down the path that brings us to today. Our journey with Nicol has given our family a lot of meaning and purpose and it's been an amazing journey.


    Given that genetic testing hasn't revealed answers for what has caused his epilepsy, how have you managed to navigate the uncertainty and maintained such positivity and strength?

    Nicol is the lead, the model and we follow his example. Nicol is a wonderful model and he shares a lot of love and joy. He will have a terrible seizure, have to be medicated, feel awful after and wake up the next day with joy. We've had to manage fear and worry, but we take on Nicol's "the sky's the limit" and "can-do" attitude. We don't have the power to control or change a lot, but we do have a choice in how we see it and how we live life. We're both controlling people, but we had to come to terms with what we couldn't control. We'll keep living to the fullest and sharing and feeling love the best we can.


    Can you tell us about The Diener School?

    When Nicol was six, he was attending a school that wasn't the best fit for him and we decided to start a school. We found great partners and professionals to help us and we started The Diener School in 2007. The school is a multi-sensory experiential approach with very talented educators, therapists and behavior specialists who work with the kids and with each other. There are elements of the connection of movement and learning, social thinking and other essential curricula and strategies needed for kids who don't learn traditionally and learn through the senses.


    What is Main Street all about?

    Main Street is a 70 unit building in Rockville, Maryland where 25% of the units are set aside for individuals with disabilities and 75% of the units are affordable, serving households at 60% or less of the area's median income. On the ground floor, there's a 10,000 square foot community space and it's an inclusive environment open to anybody through membership. It's a place for people to find their happy, to be a part of a community and feel like they belong.


    What is the Epilepsies Action Network?

    Epilepsies Action Network brings together a widespread community of epilepsies in one unified voice to lobby the federal government for funds for the epilepsies because it's an under-funded disease, and as a result, there haven't been a lot of treatment advances or breakthroughs.



    LINKS AND RESOURCES MENTIONED

    ONCE UPON A GENE - EPISODE 224 - The Complicated World of ICD10 Codes with CEO and Co-Founder of SLC6A1 Connect - Amber Freed

    https://effieparks.com/podcast/episode-224-the-complicated-world-of-icd10-codes-with-ceo-and-co-founder-of-slc6a1-connect-amber-freed

    Epilepsies Action Network

    https://www.epilepsiesactionnetwork.org/

    Rare Epilepsy Network

    https://www.rareepilepsynetwork.org/

    The Diener School

    https://thedienerschool.org/

    Main Street

    https://mainstreetconnect.org/

    46 min
  • The Bravery of the Brokenhearted - A Big Brothers Perspective on Grief From the Loss of a Sibling with Sanfilippo Syndrome with Noah Siedman

    ONCE UPON A GENE - EPISODE 225

    The Bravery of the Brokenhearted - A Big Brothers Perspective on Grief From the Loss of a Sibling with Sanfilippo Syndrome with Noah Siedman


    Noah Siedman was a big brother to Ben who had Sanfilippo Syndrome, a devastating disease that leads to childhood dementia and premature death. He joins me to talk about his sibling experience and dealing with grief.


    EPISODE HIGHLIGHTS


    As a sibling under potential pressure to not be a burden, do you still carry those feelings even after Ben's passing?

    It's hard as a sibling to see everything your parents are facing that's out of your control. As a sibling, there's a need to be on top of your own care and your own emotions. There were no casual complaints in my family growing up. It was either a disaster or business as usual. Filling in that middle space where you have a bad day and want to talk about it didn't exist. We've had to work on that as a family because that's not how we've functioned. 


    What coping mechanisms help you to write and talk about your experience?

    I came to the realization that I was going to be emotionally vulnerable, which is uncomfortable. Knowing I would have to talk about my experience and brother, I had to accept it, put it out front, and get really good at talking about it comfortably. I got more comfortable talking about the progression of my brother's disease and my feelings around him, and I used it as a shield. 


    What would you say to the young person who is living the same life you were living and what questions should people ask that person?

    The first thing that I would say, and maybe the best thing to ask that person, is about their roles. When do you feel like a sibling? When do you feel like a caregiver? When do you feel like you're an advocate? When do you feel like you are just you? I got stuck in trying to be a lot of those things at once, where the easiest role to ignore was being just me. But everything you push down morphs into something worse. Frustration turns into resentment, fear turns into trepidation, sadness becomes melancholy. 


    What are the misconceptions people have about death?

    The biggest problem with grief is that no amount of experience is applicable. It defies the ability to be prepared for it or to use your past to help you cope. I don't think grief gets easier, I think you get better at it. Those that try to give advice to people that are grieving are hanging on to the idea that that time will heal. It's not that your grief goes away, it's that you get better at it.


    How has your relationship with your sister changed?

    Ben's death brought us closer and we do a good job of communicating despite handling things differently. There's no right or wrong way to navigate life with a sibling who has a genetic disorder, so we don't judge each other and we're honest with each other. 


    As a parent, how do you help siblings to have a better experience?

    Abandon the idea that you owe siblings normalcy. My parents put a lot of effort into delivering normal childhood experiences. Instead, put that energy into helping your children articulate what they want. More important than chasing normal is helping siblings decide what's important to them and how to pursue it.


    LINKS & RESOURCES MENTIONED

    ONCE UPON A GENE - Episode 109 - A Rare Collection - What I Know For Sure with Noah Siedman, Grayson Skibington and Nash Hawkins

    https://effieparks.com/podcast/episode-109-what-i-know-for-sure


    CONNECT WITH EFFIE PARKS

    Website

    https://effieparks.com/

    Twitter

    https://twitter.com/OnceUponAGene

    Instagram

    https://www.instagram.com/onceuponagene.podcast/?hl=en

    Built Ford Tough Facebook Group

    https://www.facebook.com/groups/1877643259173346/

    47 min
  • The Complicated World of ICD10 Codes with CEO and Co-Founder of SLC6A1 Connect - Amber Freed

    ONCE UPON A GENE - EPISODE 224

    The Complicated World of ICD10 Codes with CEO and Co-Founder of SLC6A1 Connect - Amber Freed


    Advocate, rare mom and Founder of SLC6A1 Connect, Amber Freed joins me to talk about ICD-10 codes— the frustrations, the battles, and the common-sense changes we're fighting for in the rare disease community that are pivotal to research, recognition and treatment of so many rare diseases. 


    EPISODE HIGHLIGHTS


    What are ICD-10 codes?

    In 1999, the ICD-10 code was developed by the World Health Organization and it was used to track mortality coding from death certificates. It was the way people were tracked when they died, but it also became the way people were diagnosed and treated for conditions. Today, they drive so much in clinical medicine. When you go to the doctor, they will input a code of the flu, strep throat, or whatever ailment you're affected by. In a practical sense, it is how the doctor bills insurance. 


    How do misused ICD-10 codes affect our kids?

    They are the bones of our healthcare system and it impacts rare disease because when we go to the doctor and describe our children's symptoms, we need a code to represent diseases so we can be recognized as a legitimate disease and population and so that patients can be tracked in our healthcare system. 


    What does an organization need to know and what is the process for applying for an ICD-10 code?

    There are two chances per year to obtain an ICD-10 code. You submit a formal application and if you're selected, you can present before a committee and then it'll be a year to be issued a code. The application is pretty straightforward, with a scientific component and a clinical component. With a medical board of advisors, it's not hard to complete the application and gather materials. 


    How can we as a rare disease community fight to help make changes around ICD-10 code use and issuing. 

    As a community, we need to get the Rare Disease Legislative Caucus involved, get the White House involved, talk to our senators and congressmen. We need to all apply for ICD-10 codes and get loud, tweet about it, talk about it, get noticed. 



    LINKS AND RESOURCES MENTIONED

    ICD-10 Code PAG Action Plan

    Combined Brain

    https://combinedbrain.org/

    EveryLife

    https://everylife.com/

    NORD

    https://rarediseases.org/

    Global Genes

    https://globalgenes.org/

    SLC6A1 Connect

    https://slc6a1connect.org/

    Email Amber

    [email protected] 



    CONNECT WITH EFFIE PARKS

    Website

    https://effieparks.com/

    Twitter

    https://twitter.com/OnceUponAGene

    Instagram

    https://www.instagram.com/onceuponagene.podcast/?hl=en

    Built Ford Tough Facebook Group

    https://www.facebook.com/groups/1877643259173346/

    29 min
  • Rare Epilepsy Network with Ilene Penn Miller and Christina Sanlnocencio

    ONCE UPON A GENE - EPISODE 223

    Rare Epilepsy Network with Ilene Penn Miller and Christina Sanlnocencio


    Ilene Miller and Christina SanInocencio are advocates doing groundbreaking work at the Rare Epilepsy Network (REN), a volunteer network of epilepsy organizations banding together, sharing research efforts, and improving the lives of rare epilepsy patients and families. They're here to share about the inception and mission of REN and the resources available through membership.


    EPISODE HIGHLIGHTS


    What gap did establishing REN fill?

    REN was born out of the need for smaller organizations to have more information about constituents and their experiences and not being able to secure the funds to do that for themselves. Ten rare epilepsy organizations came together and were awarded funding to create the first rare epilepsy network registry that had the capacity to collect information across all rare epilepsies.


    How do you engage, continue to grow and support your community?

    We host monthly meetings and we bring in researchers, partners, speakers and other organizations to bring information to our members that they can use. Most recently we had panelists come in to talk about mortality, which is a hard topic to discuss, but our members are dealing with this in their own communities. The panel shared resources and best practices and we're assembling a collaborative working group to continue making these resources available to the network. We also have a list serve which includes all REN members where anyone can ask questions. The discussions that happen as a result are so valuable and helpful. We have a referral network so we can refer researchers, academics, clinicians and other industry professionals to the organizational partners, support groups and patient organizations they can engage in. We stay connected with these communities so we can connect the dots and match-make and help everyone find their tribe. Our monthly newsletter includes all the latest REN news, we share resources, highlight organizations and organization leaders.


    What are the future goals for REN?

    We pulse our members to see what's most important to them and two years ago, we focused on multi-disciplinary clinics because we heard from members that there aren't enough of them. We took a deep-dive into multi-disciplinary clinics and organized meetings at the Annual American Epilepsy Society Conference to bring together 100 researchers, clinicians and patient-advisory group leaders to work on the challenge. This year we're working on clustering to determine where there's synergy between epilepsy commonalities. 


    Why should a patient organization or support group join REN?

    There's no cost to be a REN member and you can engage at a pace that works for you, whether you serve on a committee and be active in work groups, or you can just watch, learn and share information as it's appropriate. 


    What resources do you wish current REN members better utilized?

    For current members, I'd like to see more engagement on social media using the hashtag #rareepilepsies in all posts. If any syndrome or disorder has epilepsy as a symptoms, using the hashtag #rareepilepsies can help build public and professional awareness. Our monthly member meetings are very actively engaged with 50+ organization leaders attending and sharing insights, so if you aren't coming to those meetings, you're missing out. 



    LINKS AND RESOURCES MENTIONED

    ONCE UPON A GENE - EPISODE 207 - Breaking Barriers in Brain Health with Tracy Dixon-Salazar, PhD

    https://effieparks.com/podcast/episode-207-breaking-barriers-in-brain-health-with-tracy-dixon-salazar-phd

    LGS Foundation

    https://www.lgsfoundation.org/

    Hope for Hypothalamic Hamartomas

    https://www.hopeforhh.org/

    American Epilepsy Society

    https://aesnet.org/

    Epilepsy Foundation 

    https://www.epilepsy.com/

    Undiagnosed Disease Network 

    https://undiagnosed.hms.harvard.edu/

    Courageous Parents Network

    https://courageousparentsnetwork.org/



    52 min
  • Krabbe Disease with Kasey Feldt

    ONCE UPON A GENE - EPISODE 222

    Krabbe Disease with Kasey Feldt


    Kasey Feldt is the mom of two- one year old Lukas and Dawson, who passed away from Krabbe disease. Kasey has become a passionate and unstoppable advocate, not only advocating for Krabbe disease, but also the newborn screening system so kids have a better chance at early detection.  


    EPISODE HIGHLIGHTS


    Can you tell us about yourself and your rare disease journey?

    My son Dawson was diagnosed with Krabbe disease. He was born a healthy baby boy and at about three months old, my husband and I noticed symptoms such as lack of head control, eating difficulties and irritability. We began testing and at about six months old, we received a diagnosis of Krabbe disease, a terminal diagnosis. We kept Dawson comfortable for about eight months following his diagnosis and he passed away at fifteen months old. 


    What is your advice for someone interested in policy advocacy?

    Search and find out who your local lawmakers are, especially your Delegate. The EveryLife Foundation is a good source for information on policy advocacy and can help you to be successful. Also, gather your disease community because the more the merrier. 


    How has advocating for Krabbe disease and newborn screening impacted you?

    It became my passion to advocate for Krabbe disease, but also rare disease in general. When Dawson passed, I knew I wanted to do this work as a career. I started working for Sisters' Hope Foundation and it's been an amazing experience and honor to Dawson. 


    LINKS AND RESOURCES MENTIONED

    ONCE UPON A GENE - EPISODE 214 - A Courageous Gift - The Power of Brain and Tissue Donation in Rare Disease Research with Anne Rugari

    https://effieparks.com/podcast/episode-214-the-power-of-brain-and-tissue-donation-in-rare-disease-research

    ONCE UPON A GENE - Episode 111 - The Importance of Newborn Screening in Every State with ALD Alliance Founder Elisa Seeger

    https://effieparks.com/podcast/episode-111-elisa-seeger-ald-alliance

    ONCE UPON A GENE - Episode 128 - Sisters’ Hope Foundation President and Founder Heidi Edwards on Recognizing ALSP Symptoms and the Importance of Genetic Testing

    https://effieparks.com/podcast/episode-128-heidi-edwards

    EveryLife Foundation

    https://everylifefoundation.org/

    KrabbeConnect

    https://krabbeconnect.org/

    Hunter's Hope

    https://www.huntershope.org/

    Krabbe Families Facebook Group

    https://www.facebook.com/groups/krabbefamilies/

    Librarey

    https://www.librarey.com/

    Sisters' Hope Foundation

    https://sistershopefoundation.org/

    World Orphan Drug 2024

    https://www.terrapinn.com/conference/world-orphan-drug-congress-usa/

    GeneDX

    https://www.genedx.com/

    Beyond The Diagnosis

    https://www.beyondthediagnosis.org/


    CONNECT WITH EFFIE PARKS

    Website

    https://effieparks.com/

    Twitter

    https://twitter.com/OnceUponAGene

    Instagram

    https://www.instagram.com/onceuponagene.podcast/?hl=en

    Built Ford Tough Facebook Group

    https://www.facebook.com/groups/1877643259173346/

    30 min
  • BeginNGS - Newborn Genomic Sequencing to End the Diagnostic Odyssey with Dr. Stephen Kingsmore, Wendy Erler and Tom DeFay

    ONCE UPON A GENE - EPISODE 221

    BeginNGS - Newborn Genomic Sequencing to End the Diagnostic Odyssey with Dr. Stephen Kingsmore, Wendy Erler and Tom DeFay


    I'm joined by Dr. Stephen Kingsmore, Wendy Erler and Tom DeFay to discuss BeginNGS, a ground-breaking initiative that stands at the forefront of genetic sequencing and rare disease diagnosis. 


    EPISODE HIGHLIGHTS


    What led to the creation of BeginNGS?

    Rare genetic diseases are an immense health ecosystem challenge- receiving a timely diagnosis. On average, it takes 4.8 years to diagnose a child with a genetic disease, and meanwhile, symptoms continue to worsen and the disease progresses. The goal of BeginNGS is to prevent or reduce the impact on children with rare genetic diseases, minimizing suffering, cost and delay of diagnosis. 


    Why is BeginNGS an important initiative to support?

    Anyone connected to the rare disease community shares the same vision for a world where every rare disease patient receives the right effective treatment at the right time. That starts with changing the diagnostic odyssey and ensuring early, fast diagnosis.


    What is the mission of the BeginNGS Consortium?

    The BeginNGS Consortium is a partnership of pharmaceutical and biotech companies, sharing a vision of the right effective treatment at the right time. Our vision is ultimately to ensure every baby born in the United States has the opportunity to be screened for rare disorders. What differentiates this program and the consortium is that the patient communities have been represented from the beginning and the patient population communities has been impressive. Some of our working groups are led by members of the patient community to make sure that what's delivered is valuable to the patients. 


    What are the major pain points to leveraging newborn screening for preventable disorders and broad use of rapid diagnostic genome sequencing?

    Pediatricians rarely order genome sequencing. We estimate only 2% of children who need the testing get it. Additionally, even when testing is ordered, it doesn't always translate into optimal treatments and there can still be delays in life-saving treatments. 


    What does the future look like for BeginNGS?

    The BeginNGS Consortium is comprised of rare disease advocacy organizations, parent support groups, healthcare systems, policy makers, experts in academic medicine, biotech companies developing new genome sequencing methods and pharmaceutical companies developing new treatments for rare genetic diseases. We hope to increase the size of the consortium so we can grow the organization and capture every voice and represent every genetic disease. Another strong aspiration is to raise grant support and funding to complete and deploy our pivotal clinical trial. 



    LINKS AND RESOURCES MENTIONED

    BeginNGS

    https://radygenomics.org/begin-ngs-newborn-sequencing/

    Alexion

    https://alexion.com/

    ONCE UPON A GENE - EPISODE 213 - Finding Strength In Every Step

    https://effieparks.com/podcast/episode-213-finding-strength-in-every-step

    Frontiers 2024 Conference

    https://radygenomics.org/frontiers-conference/



    CONNECT WITH EFFIE PARKS

    Website

    https://effieparks.com/

    Twitter

    https://twitter.com/OnceUponAGene

    Instagram

    https://www.instagram.com/onceuponagene.podcast/?hl=en

    Built Ford Tough Facebook Group

    https://www.facebook.com/groups/1877643259173346/

    39 min
  • A Rare Collection - From Financial Strain to Supportive Gain - A Call For Action

    ONCE UPON A GENE - EPISODE 220

    A Rare Collection - From Financial Strain to Supportive Gain - A Call For Action


    There's power in storytelling- for the listener and the storyteller. A Rare Collection is a monthly series featuring people from the rare disease community, sharing a story with a common theme. 


    EPISODE HIGHLIGHTS

    Katie Scheid

    The beginning of my care-giving journey was filled with trauma, disbelief and a complete re-shaping of the life I knew. My daughter Millie is three and a half years old and I am her full-time, unpaid caregiver. She suffered a severe stroke just before she was born, resulting in complete care for the rest of her life. She is blind, can't sit or hold her head up, can't speak or control her body's movements. She's tube-fed and has over 50 seizures each day. In Washington, kids like Millie, whose needs qualify for in-home care, can have any person be their hired care-giver, except a parent. Millie was assessed and allocated for 185 hours per month of paid, in-home care-giving to alleviate the burden on us as her primary care-givers. After 6 months, we didn't receive a single applicant. I quit my job to be her care-giver and we've struggled to live on one income since. Parents Empowering Parents of Washington (PEPWA) is a group of over 550 advocate members working to change the laws in Washington. We are leading the fight to access the service our kids qualify for and we demand better for ourselves and our kids.


    Lindsey Topping-Schuetz

    On January 10th, I testified before the Washington State House Committee on Human Services, Youth and Early Learning in favor of HB2184. This legislation would authorize payment of parental care-givers of minor children with developmental disabilities. January 10th is a significant day for my family. Seven years ago, my husband and I would leave the hospital for the first time with our son, Owen. He spent 103 days in the NICU. We walked down the hallway lined with staff and family, everyone clapping and cheering. Owen came home dependent on oxygen and a feeding tube. He would have dozens of episodes a day that left him struggling to breathe. At three years old, Owen was granted hours to pay someone other than my husband or I to care for him. It's nearly impossible to utilize these hours because there's a shortage of nurses and they're not provided with the medical training required to care for my son. Care-giving a child like Owen goes well beyond parenting. The financial hardship has burdened our entire extended family. HB2184 has the ability to change the lives of families like mine. It is time for Washington to acknowledge the work of parent care-givers in the same way as all other care-givers.


    Emily Holloway

    I'm the mom of four children and I live in Virginia. Our daughter Chloe was diagnosed with a rare disease of her lymphatic system. While her life was seemingly normal for the first eight years, we drove head first into the medical world when she began showing signs of the disease. Working full time wasn't realistic, so I left my teaching career and our family income was cut in half. Chloe receives g-tube feedings and several medications, she needs assistance bathing and walking, she attends weekly therapy sessions and she requires a lot of care. I was given the opportunity to become her paid care-giver and I was thrilled to be home caring for Chloe, contributing to our finances, an opportunity that ended when the pandemic and medical lockdown concluded. Medicaid believes care-takers now need to head back to work and hire care-takers for their children. Additionally, there's a maximum amount of care hours a child can receive, regardless of their needs. The best interest of children is missing from these regulations. We hope our legislators will allow the parents who know their children best, love them the most and are the biggest advocates for their well-being, to remain their care-takers and receive a small reimbursement to help pay living expenses. 


    18 min
  • Genomics England Clinical Lead for Genetic Counseling - Amanda Pichini

    ONCE UPON A GENE - EPISODE 219

    Genomics England Clinical Lead for Genetic Counseling - Amanda Pichini


    Amanda Pichini is a genetic counselor from Genomics England, here to share their initiatives and mission. 


    EPISODE HIGHLIGHTS

    What is your role at Genomics England and how did your career develop?

    I work at Genomics England as the Director of Clinical Implementation and I'm responsible for the strategic clinical leadership for our products and services, ensuring research, diagnostics and clinical programs we support are in line with the latest healthcare standards and research. Prior to joining Genomics England, I worked as a genetic counselor, a profession I was interested in for a long time. When I started studying biology, I was keen to do something that allowed me to communicate and speak to people, but still be immersed in science. While my role isn't patient-facing now, I bring my genetic counselor skills to understand the complexities of genetics in healthcare and how we communicate to various audiences to design and deliver our programs.


    What are the current initiatives at Genomics England?

    Since the 100,000 Genomes Project, we are focused on working with the NHS to provide genome sequencing as a standard clinical test. We've worked hard to ensure healthcare professionals understand how to help families through the process, manage their expectations and potential results of genome sequencing. We're also focused on looking at different types of sequencing technology we can use to enhance the testing and care for cancer patients, and also a newborn genomes program which is part of a large-scale national research study called the Generation Study. This study will sequence the genomes of 100,000 newborn babies with a goal of understanding if sequencing in the newborn period can help identify rare conditions earlier in life, with the ideal goal of improving the quality of life and outcomes for the babies identified as having a rare condition.


    Can you talk more about the newborn screening?

    Like in the US, we do a heel prick when a baby is about 5 days old at the parent's discretion. We recommend it as public health and to look for rare conditions that could be treated if found early. We currently test for 9 conditions, but the Generation Study is an optional screening in addition to standard newborn screening. It will be available to parents at different hospital sites, a baby doesn't already need to be ill and parents don't have to have a known history to participate. At birth, a small amount of cord blood will be taken and that sample used to carry out genome sequencing and to look for around 200 rare conditions that we feel would have an early intervention option if found through screening. We will follow up on every test, with much closer monitoring and follow-up where a condition may be positive.


    LINKS AND RESOURCES MENTIONED

    Genomics England

    https://www.genomicsengland.co.uk/

    Genetic Alliance UK

    https://geneticalliance.org.uk/

    Genetic Alliance US

    https://geneticalliance.org/



    CONNECT WITH EFFIE PARKS

    Website

    https://effieparks.com/

    Twitter

    https://twitter.com/OnceUponAGene

    Instagram

    https://www.instagram.com/onceuponagene.podcast/?hl=en

    Built Ford Tough Facebook Group

    https://www.facebook.com/groups/1877643259173346/

    44 min

About Once Upon A Gene

From the publisher's feed

As a new parent of a child with a rare genetic syndrome, I was lost. There was no guide. There was no rulebook. This was not what I had imagined. As I navigated my way through this new reality, I…

More shows like Once Upon A Gene

Radiolab by WNYC Studios

Radiolab

43,766 Listeners

Criminal by Vox Media Podcast Network

Criminal

37,512 Listeners

DNA Today: A Genetics Podcast by Kira Dineen, Gene Pool Media

DNA Today: A Genetics Podcast

157 Listeners